Back to Search Start Over

Evolution of clinical features in possible DLB depending on FP-CIT SPECT result

Authors :
Walker, Zuzana
Moreno, Emilio
Thomas, Alan
Inglis, Fraser
Tabet, Naji
Stevens, Tim
Whitfield, Tim
Aarsland, Dag
Rainer, Michael
Padovani, Alessandro
Moreno Carretero, Mj
Leitha, T
Lomeña, F
Lladó, A
Serena, A
Ferrer, Ga
Daumal, J
Neciga, Eg
Ransmayr, G
Gabriel, M
Danek, A
Lozano, Dm
Howe, K
Prosser, J
Sandhu, P
Paghera, B
Brown, D
Castelnovo, G
Collombier, L
Mazzucchi, S
Volterrani, D
Ceravolo, R
La Fougere, C.
Source :
Neurology
Publication Year :
2016
Publisher :
Lippincott, Williams & Wilkins, 2016.

Abstract

Objective: To test the hypothesis that core and suggestive features in possible dementia with Lewy bodies (DLB) would vary in their ability to predict an abnormal dopamine transporter scan and therefore a follow-up diagnosis of probable DLB. A further objective was to assess the evolution of core and suggestive features in patients with possible DLB over time depending on the 123I-FP-CIT SPECT scan result.\ud \ud Methods: A total of 187 patients with possible DLB (dementia plus one core or one suggestive feature) were randomized to have dopamine transporter imaging or to follow-up without scan. DLB features were compared at baseline and at 6-month follow-up according to imaging results and follow-up diagnosis.\ud \ud Results: For the whole cohort, the baseline frequency of parkinsonism was 30%, fluctuations 29%, visual hallucinations 24%, and REM sleep behavior disorder 17%. Clinician-rated presence of parkinsonism at baseline was significantly (p = 0.001) more frequent and Unified Parkinson’s Disease Rating Scale (UPDRS) score at baseline was significantly higher (p = 0.02) in patients with abnormal imaging. There was a significant increase in UPDRS score in the abnormal scan group over time (p < 0.01). There was relatively little evolution of the rest of the DLB features regardless of the imaging result.\ud \ud Conclusions: In patients with possible DLB, apart from UPDRS score, there was no difference in the evolution of DLB clinical features over 6 months between cases with normal and abnormal imaging. Only parkinsonism and dopamine transporter imaging helped to differentiate DLB from non-DLB dementia.

Details

Language :
English
ISSN :
00283878
Database :
OpenAIRE
Journal :
Neurology
Accession number :
edsair.doi.dedup.....cece647af77a5594d68f525273b9d4bc